Deal watch: Amgen builds secondary hyperparathyroidism [corrected] pipeline.
Man Tsuey
MT
Tse
D000069449:Cinacalcet; D004345:Drug Industry / Q000191:economics* / Q000639:trends*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D009281:Naphthalenes / Q000627:therapeutic use; D044169:Receptors, Calcium-Sensing / Q000187:drug effects / Q000502:physiology; D006435:Renal Dialysis / Q000009:adverse effects
D009281:Naphthalenes; D044169:Receptors, Calcium-Sensing; D000069449:Cinacalcet